TY - JOUR AR - GDT-2021-1-101 TI - COVID-19 Vaccine Acceptance by Patients Attending a Primary Health Care Facility in Durban AU - Akm Monjurul , Hoque AU - Somaya , Buckus AU - Maariyah , Hoque AU - ABM Mahbub , ul Alam AU - Nisha , Singh AU - ME , Hoque JO - Global Drugs and Therapeutics PY - 2021 DA - Thu 11, Feb 2021 SN - 2733-256X DO - http://dx.doi.org/10.31487/j.GDT.2021.01.01 UR - https://www.sciencerepository.org/covid-19-vaccine-acceptance-by-patients-attending-a-primary-health_GDT-2021-1-101 KW - COVID-19 pandemic, Kwadabeka CHC, out-patient, South Africa AB - Introduction: There is no specific treatment and vaccine for COVID-19 yet. The prospective vaccine is the primary prevention and is the promising preventive strategy to gain herd immunity. The study aimed to identify COVID-19 vaccine acceptance rate among primary health care attendees at Durban, South Africa. Method: A questionnaire based cross-sectional study was conducted at the Kwadabeka Community Health Centre, Durban, South Africa. Chi-square test and logistic regression were carried out to identify the factors for COVID-19 vaccine acceptability. P-values <0.05 were reported and considered statistically significant. Results: Almost two-thirds (61.4%) of the participants reported that they would accept a COVID-19 vaccine. Logistic regression analysis found that respondents’ attitude on whether “COVID-19 pandemic will be dealt with successfully” was 2.3 times more likely to accept the vaccine (OR=2.3, 95% CI: 1.3-3.8, p<0.05) and good practice on “use of a face mask to public places were 3 times more likely to accept the vaccine (OR=3.0, 95% CI: 1.5-6.1, P<0.05). On the contrary, knowledge on “only elderly people die from COVID-19 (False)” revealed that 44% were less likely to accept the vaccine (OR=0.56, 95% CI: 0.33-0.95, P<0.05) and practice on social distance “keep a distance of 1-2 m in public places” was 69% less likely to accept the vaccine (OR=0.31, 95% CI: 0.15-0.63, p<0.05). Conclusion: The COVID-19 vaccine acceptance rate is comparable with other studies. However, community-based studies and a mass educational and communication campaign to promote the COVID-19 vaccination coverage to the general population are recommended.